Clinical Trials Logo

Periorbital Disorder clinical trials

View clinical trials related to Periorbital Disorder.

Filter by:
  • None
  • Page 1

NCT ID: NCT05672407 Withdrawn - Hemorrhage Clinical Trials

The Role of Local Tranexamic Acid on Periorbital Oculoplastic Surgery

Start date: September 1, 2023
Phase: Phase 4
Study type: Interventional

This study investigates the effect of tranexamic acid, a medication that helps reduce bleeding, in patients undergoing surgeries around their eyes.

NCT ID: NCT04745078 Completed - Clinical trials for Periorbital Disorder

Carboxytherapy for Periorbital Dark Circles

Start date: January 1, 2017
Phase: N/A
Study type: Interventional

the study evaluates carboxytherapy for the treatment of periorbital dark circles

NCT ID: NCT03393624 Completed - Clinical trials for Periorbital Disorder

Influence of Sleep Quality in Patients With Periorbicular Hyperchromia

Start date: October 1, 2017
Phase:
Study type: Observational

Periorbital hyperchromia (POH) or periorbital hyperpigmentation, commonly known as "dark circles", is a relatively common condition and a frequent reason for dermatological consultation. It is defined as brown-colored pigmentation, ranging from light to dark, which mainly involves the lower eyelids. POH affects individuals over a wide age range, including both sexes and all ethnicities, and is associated with a tired and aged facial appearance. The most commonly affected people are those with the highest skin phototypes. Although the prevalence is similar between sexes and age groups, POH is a more frequent complaint in women. The dark circles characteristic of POH can negatively impact patients' quality of life, although it is not a condition associated with morbidity. Popularly it is believed that the poor quality of sleep is a factor responsible for its appearance, but there is no consistent data in the literature that prove this.

NCT ID: NCT03238105 Active, not recruiting - Clinical trials for Periorbital Disorder

Treatment of Periorbicular Hyperchromia Comparing 10% Thioglycolic Acid Peeling Versus Pulsed Intense Light

Start date: August 1, 2017
Phase: Phase 4
Study type: Interventional

Periorbital hyperchromia (POH) or periorbital hyperpigmentation, commonly known as "dark circles", is a relatively common condition and a frequent reason for dermatological consultation. It is defined as brown-colored pigmentation, ranging from light to dark, which mainly involves the lower eyelids. POH affects individuals over a wide age range, including both sexes and all ethnicities, and is associated with a tired and aged facial appearance. The most commonly affected people are those with the highest skin phototypes. Although the prevalence is similar between sexes and age groups, POH is a more frequent complaint in women. The dark circles characteristic of POH can negatively impact patients' quality of life, although it is not a condition associated with morbidity. Despite its high prevalence, only a few well-designed studies were done to evaluate its therapeutic options. The intense pulsed light (IPL) and the thioglycolic acid are safe treatment options and promote the improvement of dark circles, but it is not known if one treatment differs from the other in relation to efficacy and adverse effects.